1 – 10 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, Srinivas LU
; Martin de la Fuente, Laura
LU
; Li, Minerva
LU
; Tang, Guyuan
; Ebbesson, Anna
LU
; D'Incalci, Maurizio
; Marchini, Sergio
; Mannarino, Laura
; Måsbäck, Anna
LU
and Malander, Susanne
LU
, et al.
(2025)
SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
Westbom-Fremer, Sofia LU
; Tran, Lena
LU
; Ebbesson, Anna
LU
; Martin de la Fuente, Laura
LU
; Jönsson, Jenny-Maria
LU
; Kannisto, Päivi
LU
; Veerla, Srinivas
LU
and Hedenfalk, Ingrid
LU
(2025)
In Cancer Immunology Immunotherapy
74.
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
Malmström, Erik LU ; Malmström, Lars LU ; Hauri, Simon LU ; Mohanty, Tirthankar LU ; Scott, Aaron LU ; Karlsson, Christofer LU ; Gueto-Tettay, Carlos LU ; Åhrman, Emma LU ; Nozohoor, Shahab LU
and Tingstedt, Bobby
LU
, et al.
(2025)
In Cell
188(10).
p.16-2822
- Contribution to journal › Article
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Corvigno, Sara ; Fernebro, Josefin LU ; Karlsson, Josefin Severin ; Mezheieusky, Artur ; Martín-Bernabé, Alfonso ; De La Fuente, Laura Martin LU ; Westbom-Fremer, Sofia LU
; Carlson, Joseph W.
; Klein, Christian
and Kannisto, Paivi
LU
, et al.
(2025)
In Gynecologic Oncology
193.
p.148-155
- Contribution to journal › Article
- 2024
-
Mark
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
- Contribution to journal › Article
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Fleischer, Thomas ; Haugen, Mads Haugland ; Ankill, Jørgen ; Silwal-Pandit, Laxmi ; Børresen-Dale, Anne Lise ; Hedenfalk, Ingrid LU
; Hatschek, Thomas
; Tost, Jörg
; Engebraaten, Olav
and Kristensen, Vessela N.
(2024)
In Molecular Oncology
18(8).
p.2042-2059
- Contribution to journal › Article
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
Linder, A ; Westbom-Fremer, S LU
; Mateoiu, C
; Olsson Widaja, A
; Österlund, T
; Veerla, S
LU
; Ståhlberg, A
; Ulfenborg, B
; Hedenfalk, I
LU
and Sundfeldt, K
(2024)
In Human Reproduction
39(5).
p.1141-1154
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Lauss, Martin LU ; Phung, Bengt LU ; Borch, Troels Holz ; Harbst, Katja LU
; Kaminska, Kamila
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Yuan, Joan
LU
; Nielsen, Kari
LU
and Ingvar, Christian
LU
, et al.
(2024)
In Nature Communications
15(1).
- Contribution to journal › Article
- 2023
-
Mark
Deciphering the normal-like molecular subtype of breast cancer
Veerla, Srinivas LU
; Kimbung, Siker
LU
; Vallon-Christersson, Johan
LU
; Ebbesson, Anna
LU
and Hedenfalk, Ingrid
LU
(2023)
AACR Special Conference in Cancer Research: Advances in Breast Cancer Research
- Contribution to conference › Poster
-
Mark
CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer
Briem, Oscar LU
; Källberg, Eva
LU
; Kimbung, Siker
LU
; Veerla, Srinivas
LU
; Stenström, Jenny
; Hatschek, Thomas
; Hagerling, Catharina
LU
; Hedenfalk, Ingrid
LU
and Leandersson, Karin
LU
(2023)
In Cancers
15(4).
- Contribution to journal › Article